Vitamin D undergoes a two-step hydroxylation process to become biologically active. The process begins with 7-dehydrocholesterol, a precursor located in the skin. Upon exposure to ultraviolet B (UVB) radiation from sunlight, this precursor is converted to cholecalciferol (vitamin D3).
Once formed, cholecalciferol travels through the bloodstream to the liver, where it undergoes hydroxylation at the 25th carbon position by the enzyme 25-hydroxylase. This converts it into 25-hydroxyvitamin D3 (calcidiol). Calcidiol is the major circulating form of vitamin D in the body and serves as the best indicator of vitamin D status. However, while it has some biological activity, it is not the most potent form.
The next critical transformation occurs in the kidney, where the enzyme 1-alpha-hydroxylase hydroxylates calcidiol at the 1-alpha position, producing 1,25-dihydroxyvitamin D3 (calcitriol). This molecule is the biologically active form of vitamin D, functioning as a hormone.
Calcitriol binds to vitamin D receptors (VDRs) in target tissues, exerting key physiological effects. It plays a crucial role in:
- Enhancing intestinal absorption of calcium and phosphate
- Promoting bone mineralization and remodeling
- Regulating renal reabsorption of calcium
- Maintaining overall calcium and phosphate balance
Without this active metabolite, the body would struggle to maintain proper bone health and mineral homeostasis.
❌ Why the Other Options Are Incorrect:
None of these is incorrect because the correct active metabolite is clearly listed among the options.
25-hydroxyvitamin D3 is the storage and circulating form, not the fully active hormonal form. Its primary role is as a reservoir that can be converted when needed.
7-dehydrocholesterol is the precursor molecule in the skin that starts the pathway upon UVB exposure. It is not biologically active.
1-hydroxyvitamin D3 is an incorrect or incomplete term. The physiologically relevant molecule is 1,25-dihydroxyvitamin D3, not a single hydroxylated form at position 1 alone.